Menu

Member

133 posts

Posts (133)

Member SYRS 3 years ago #21

2023 the year of biotech acquisitions. Syros next?!?

Member SYRS 3 years ago #23

Bert Cam slow down on the buying. Leave some for others. Geez! Go $SYRS

Member SYRS 3 years ago #24

Bert and I just bought and bought big! Go $SYRS

Member SYRS 3 years ago #25

Syros is next! Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A

Member SYRS 3 years ago #26

$SYRS major investor is Flagship Pioneer, founded by Noubar Afeyan, founder of Moderna. 2023 is the year of biotech acquisitions.

Member SYRS 3 years ago #27

$SYRS will hit double digits with the next data printout in May/June 2023

Member NXGL 3 years ago #28

Bain Life Sciences is one of the largest, smartest instututional investors in the biotech space. At last print they were long 2 million plus shares of SYROS in a highly slective portfolio of LS investments. That investment equates to 10 percent of SYROS's market cap. They get clyincally constructive on emerging biotech that has the ingedients of SYROS - deep proven experienced management team, compelling science and market opportunity, and balance sheets with verifiable cash runway - and they get in early at attractive risk adjusted bases before known catalysts play out. Good luck to all

Member SYRS 3 years ago #29

Big rally week for SYRS. Typically this occurs before big news is announced

Member SYRS 3 years ago #30

Sign it’s going to launch